MedTrace Logo

Treatment of Transcranial Alternating Current Stimulation（tACS）on Cerebellar Ataxia

NCT05557786 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 164

Last updated 2024-07-12

No results posted yet for this study

Summary

This is a longitudinal, triple-blind, randomized-controlled, prospective interventional study assessing patients with cerebellar ataxia, including spinocerebellar ataxia type 3 (SCA3) and multiple system atrophy-cerebellar type (MSA-C), to examine the efficacy, safety, and tolerability of transcranial alternating current stimulation (tACS) for up to 3 months.

Conditions

  • Spinocerebellar Ataxia Type 3
  • Multiple System Atrophy-cerebellar Type

Interventions

DEVICE

Transcranial Alternating Current Stimulation

Cerebellar Transcranial Alternating Current Stimulation（tACS）

Sponsors & Collaborators

  • First Affiliated Hospital of Fujian Medical University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-07
Primary Completion
2024-03-09
Completion
2024-05-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05557786 on ClinicalTrials.gov